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Apparently balanced chromosomal rearrangements in individuals with major congenital anomalies represent natural experiments of
gene disruption and dysregulation. These individuals can be studied to identify novel genes critical in human development and to an-
notate further the function of known genes. Identiﬁcation and characterization of these genes is the goal of the Developmental Genome
Anatomy Project (DGAP). DGAP is a multidisciplinary effort that leverages the recent advances resulting from the Human Genome Pro-
ject to increase our understanding of birth defects and the process of human development. Clinically signiﬁcant phenotypes of individ-
uals enrolled in DGAP are varied and, inmost cases, involvemultiple organ systems. Study of these individuals’ chromosomal rearrange-
ments has resulted in themapping of 77 breakpoints from 40 chromosomal rearrangements by FISHwith BACs and fosmids, array CGH,
Southern-blot hybridization, MLPA, RT-PCR, and suppression PCR. Eighteen chromosomal breakpoints have been cloned and se-
quenced. Unsuspected genomic imbalances and cryptic rearrangements were detected, but less frequently than has been reported pre-
viously. Chromosomal rearrangements, both balanced and unbalanced, in individuals with multiple congenital anomalies continue to
be a valuable resource for gene discovery and annotation.Introduction
Approximately 1 in 2000 newborns has a de novo balanced
chromosomal rearrangement.1 Although the majority of
these individuals will have no discernible clinical pheno-
type, the risk for a congenital anomaly in this population
is two to three times higher than that observed in an unse-
lected population of newborns, for which the risk of anom-
alies is 2%–3%.1 Clinical ﬁndings observed in patients with
such chromosomal rearrangements are thought to be
caused by disruption or dysregulation of a gene (or genes)
at or near the breakpoint. The underlying pathogenetic
mechanismmay result froman intragenic break,2,3 fromac-
companying genomic copy alterations at or in the vicinity
of the breakpoint,4 from production of a chimeric gene,5
or from a position effect on a gene (or genes) distant from
thebreakpoint.6 In addition, chromosomal rearrangements
may disrupt noncoding RNA genes or conserved nongenicsequences, two elements whose roles in genome architec-
ture and gene regulation have yet to be elucidated fully.7,8
The resulting physiological consequences can include com-
plete abrogation of the protein if the corresponding allele is
imprinted or otherwise mutated, haploinsufﬁciency, ele-
vatedexpression, or creationof a fusionproteinwith adom-
inant-negative effect or novel gain of function.
Use of chromosomal rearrangements as signposts for
genes important in human disease is well documented.9–15
Historically, these chromosomal rearrangements were
investigated with conventional cytogenetic banding
methods and subsequent arduous positional-cloning pro-
jects. More recently, molecular cytogenetic characteriza-
tions using labeled DNA from bacterial artiﬁcial chromo-
somes (BACs) in ﬂuorescence in situ hybridization (FISH)
and array comparative genomic hybridization (aCGH)
studies have allowed more precise and rapid localization of
breakpoints. Recent studies of patients with phenotypic1Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, USA; 2Division of Genetics, Department of
Medicine, Brigham and Women’s Hospital, Boston, MA 02115, USA; 3Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and
Women’s Hospital and Harvard Medical School, Boston, MA 02115, USA; 4Department of Genetics, Harvard Medical School, Boston, MA 02115, USA;
5Genetics Division, Department of Pediatrics, Children’s Hospital Boston and Harvard Medical School, Boston, MA 02115, USA; 6Molecular Neurogenetics
Unit, Center for Human Genetic Research, Massachusetts General Hospital and Department of Genetics, Harvard Medical School, Boston, MA 02114, USA;
7Division of Genetics, Children’s Hospital Boston and HarvardMedical School, Boston, MA 02115, USA; 8Department of Genetics, University of Alabama at
Birmingham, Birmingham, AL 35294, USA; 9Division of Laboratory and Genomic Medicine, Department of Pathology, Washington University School of
Medicine, St Louis, MO 63110, USA; 10Medical Genetics Division, Hoˆpital Ste. Justine, University of Montreal, Montreal H3T 1C5, Canada; 11Renal Section,
Department of Medicine, Boston University Medical Center, Boston, MA 02118, USA; 12Department of Neurology, Harvard Medical School, Boston, MA
02114, USA
13All editorial responsibility for this article was handled by an associate editor of the Journal.
*Correspondence: cmorton@partners.org
DOI 10.1016/j.ajhg.2008.01.011. ª2008 by The American Society of Human Genetics. All rights reserved.
712 The American Journal of Human Genetics 82, 712–722, March 2008
abnormalities and chromosomal rearrangements used the
above methods and have revealed that some presumably
balanced rearrangements include cryptic deletions or more
complex rearrangements.16,17 However, these investiga-
tions have examined relatively small numbers of patients
andhavenot speciﬁcally studied thebreakpoints at the level
of the DNA sequence.
In this study, we describe the comprehensive examina-
tion of 40 reportedly balanced chromosomal rearrange-
ments from patients with clinical abnormalities. These
patients were ascertained through the Developmental Ge-
nomeAnatomyProject (DGAP).DGAP isamultidisciplinary
study bringing together cytogeneticists, molecular biolo-
gists, and developmental biologists to understand the ge-
netic basis of birth defects and the underlyingmolecular ba-
sisofdevelopment.This goal ispursued throughthe studyof
individuals with apparently balanced chromosomal rear-
rangements who also have major congenital anomalies.
Through leveraging of the resources generated by the Hu-
man Genome Project, the breakpoints of these rearrange-
ments can be mapped expeditiously to discover and anno-
tate genes likely to be critical in mammalian development.
As a consequenceof this effort,we characterized77break-
points from40chromosomal rearrangements byusing FISH
with BACs and fosmids, array CGH, Southern-blot hybrid-
ization, multiplex ligation-dependent probe ampliﬁcation
(MLPA), RT-PCR, and suppression PCR. Eighteen chromo-
somal breakpoints were cloned and sequenced. Herein we
report the detailed analyses of these rearrangements includ-
ing identiﬁcation of cryptic copy-number alterations and
complex rearrangements.
Material and Methods
Patients and Cell Lines
Individuals were enrolled in the DGAP study after identiﬁcation of
an apparently balanced chromosomal rearrangement and at least
one clinically signiﬁcant congenital anomaly (e.g., cleft lip). All hu-
man study protocols were reviewed and approved by the Partners
Health Care System Human Research Committee. Lymphocyte cell
transformation was performed at the Massachusetts General Hospi-
tal Genomics Core Facility in the Center for Human Genetic Re-
search (Boston, MA). Cell lines prepared from individuals with sim-
ilar phenotypic and cytogenetic criteria were obtained from the
National Institute of General Medical Sciences (NIGMS) Human
Genetic Cell Repository (Coriell Cell Repositories, Camden, NJ).
Cytogenetic Analysis
Metaphase chromosomes were prepared from lymphoblastoid cell
lines or ﬁbroblast cultures according to routine protocols. Chro-
mosomes were GTG banded via standard methods, and at least
ten metaphase spreads were examined per patient. Resolution
for the GTG-banded chromosomes was R 550 bands.
Probes for Fluorescence In Situ Hybridization
BACs forbreakpointmappingof chromosomal rearrangementswere
selected with the University of California Santa Cruz Genome
Browser and Database and the NCBI Human Genome Browser andTheDatabase. BACs from the RP1, RP3, RP4, RP5, RP6, RP11, and
RP13 libraries and fosmids from the wi2 library were obtained
from Children’s Hospital Oakland Research Institute (CHORI, Oak-
land, CA). BACs from the CTB, CTC, and CTD libraries were ob-
tained from Invitrogen (Carlsbad, CA). DNA was isolated in
accordancewitha standardprotocol consistingofalkaline lysis, neu-
tralization, and ethanolprecipitation (QIAGEN,Valencia,CA). Poly-
merase chain reaction (PCR) fragments were generated by routine
methods. PCR fragments were either gel puriﬁedwith the QIAquick
Gel Extraction Kit (QIAGEN) or puriﬁed with the QIAquick PCR Pu-
riﬁcation Kit (QIAGEN). Isolated DNA was labeled directly with ei-
ther SpectrumGreen- or SpectrumOrange-conjugated dUTP, via
the Nick Translation Reagent Kit from Abbott Molecular/Vysis
(Des Plaines, IL), or indirectly with biotin or digoxygenin via the
DIG DNA Labeling Kit or Biotin DNA Labeling Kit (Roche Diagnos-
tics, Indianapolis, IN). Cot-I DNA was added to suppress repetitive
sequences, and probes were ethanol precipitated and resuspended
in Hybrisol containing 50% formamide (Abbott Molecular/Vysis).
Fluorescence In Situ Hybridization
Metaphase chromosome preparations from each DGAP case were
prepared on glass slides in accordance with standard hypotonic ly-
sis and ﬁxation, followed by dehydration in a series of ethanol
washes and probe application. Both probes and chromosomes
were denatured simultaneously at 72C for 2 min and incubated
overnight at 37C in a HYBrite apparatus (Abbott Molecular/
Vysis). Slides were washed in 50% formamide/23SSC at 37C for
20 min and 23SSC at 37C for 20 min. 40,60-diamidino-2-phenyl-
indole hydrochloride (DAPI) was used as counterstain. Hybridiza-
tion results were assessed with a Zeiss Axioskop 2 epiﬂuorescence
microscope (Thornwood, NY) or an Olympus BX51 microscope
(Center Valley, PA), and images were acquired with an Applied
Imaging CytoVision cytogenetics workstation (Santa Clara, CA).
A minimum of ten metaphases were scored per probe (set).
Array Comparative Genomic Hybridization
aCGH was performed with either Spectral Genomics 2600 BAC ar-
rays (Houston, TX) with an ~1 Mb resolution or Agilent Technol-
ogies 244K (G4411B) oligonucleotide arrays consisting of 60-mer
oligonucleotides spaced at 8.9 kb (Santa Clara, CA).
Southern-Blot Analysis
Southern blotting was performed by standard methods. BAC se-
quences of breakpoint critical regions were examined with Repeat
Masker to identify regions from which unique probes could be
generated. Genomic DNA probes of ~200 to ~1500 base pairs
(bp) were prepared from these nonrepetitive sequences by PCR.
PCR products were labeled with the Megaprime DNA labeling
Kit (Amersham Biosciences, Piscataway, NJ). Aberrant bands de-
tected in patient samples but absent in control samples indicated
localization of the breakpoint within these restriction fragments.
Breakpoint Cloning
Rearrangement breakpoints were cloned via modiﬁcations of the
suppression PCR protocol18 as described.19 Cloned junction frag-
ments were sequenced by standard methods.
Fusion Transcript Ampliﬁcation
Fusion transcript ampliﬁcation was performed with RT-PCR
according to routine protocols. Primer sequences are previously
described.2,20American Journal of Human Genetics 82, 712–722, March 2008 713
Candidate-Gene Transcript Analysis
Gene dosage of selected candidate genes was investigated with
MLPA as described.21
Analysis of Sequence Motifs at Breakpoint Regions
Eighteen sequenced breakpoints (from DGAP cases 003, 011, 012,
032, 090, 097, 105, 107, and 151) were used for this analysis. A
nonredundant set of sequences, consisting of 15 bp upstream
and downstream of each breakpoint (i.e., 30 to 60 bp per break-
point, depending on the presence and length of deletions at the
breakpoint itself), were extracted and used for analysis. This
yielded 841 bp of breakpoint-associated sequence. A Poisson distri-
bution was used to evaluate whether an excess of observations of
each motif was present in the breakpoint-associated sequence. For
each evaluated motif, background frequencies were estimated by
their frequency of occurrence in an arbitrary 1Mb of human geno-
mic sequence (from chromosome 10).
Results
Samples were obtained from individuals with a wide spec-
trum of anomalies, and no speciﬁc anomaly or organ sys-
tem was the focus of enrollment in the DGAP study. Phe-
notypes of DGAP cases include physical ﬁndings such as
cleft lip and palate, neurological impairments such as ob-
sessive-compulsive disorder, and multisystem abnormali-
ties (Figure 1 and Table 1).
Breakpoint Mapping
Cell lines established from individuals enrolled in DGAP
were examined initially with FISH with BAC probes to de-
ﬁne the genomic region of the breakpoints. A series of iter-
ative experiments with clones in the region was performed
until one clone produced a ‘‘split signal.’’ A genomic clone
was determined to contain the breakpoint if signals were
observed on the normal chromosome and both derivative
chromosomes. Through the use of overlapping end-se-
quenced BAC clones and smaller probes, such as fosmids
and PCR fragments, breakpoint critical regions were nar-
rowed further to as small a region as 0.4 kilobases (kb).
As a result of the FISH analyses, the initial reported kar-
yotype designations determined by GTG banding were re-
vised for 18 of the 40 chromosomal rearrangements. For all
but one rearrangement, the reﬁned breakpoint shifted to
the adjacent GTG band or next most adjacent GTG band.
This ﬁnding is not surprising given the lower resolution
of GTG banding compared with FISH and the relatively
subjective nature of breakpoint designation via GTG band-
ing. For the single case in which the breakpoints mapped
were substantially different from those reported, the GTG-
banded karyotype was reviewed and the FISH-based break-
point assignments conﬁrmed.
FISH analyses also revealed that a number of DGAP cases
have deletions (Table 2). Deletions ranging in size from
~500 kb to 12 megabases (Mb) were found in 15 of 40
DGAP cases analyzed. Themajority of these deletionsmap-
ped to the breakpoints, although ﬁve (DGAP089, 159, 169,714 The American Journal of Human Genetics 82, 712–722, March174, and 200) mapped at a distance from the breakpoint
and one (DGAP107) was completely independent of the
breakpoint. Three cases (DGAP106, 159, 169) had dele-
tions at both breakpoints. The 12 Mb deletion seen in
DGAP089 was reported to us during the course of our study
by the submitting geneticist after detection by conven-
tional (metaphase) CGH.22 This ﬁnding was conﬁrmed
and the boundaries of the deletion were reﬁned by Spectral
Genomics 2600 BAC aCGH.23 In the case of the DGAP107
deletion, the referring physician reported a serendipitous
discovery of a deletion in the Smith-Magenis syndrome
critical region during a laboratory study of patients
with sleep disturbances; DGAP107 had been selected as
a control specimen for probe validation. Once this deletion
was reported to us, the deletion interval was veriﬁed by
FISH.20
We identiﬁed only two complex rearrangements among
this reported series of DGAP cases. DGAP018 had a reported
karyotype of 46,XX,ins(3;1)(q23;p22p32). FISH analysis
with ﬁve BACs that mapped to 1p32 through 1p21 hybrid-
ized to what appeared to be a derivative chromosome 2,
der(2). Multiplex FISH (M-FISH) was performed and re-
vealed that material from chromosome 1 was inserted
into the short arm of chromosome 2, and material from
chromosome 2 was inserted into the long arm of chromo-
some 3. FISH experiments using BACs localized to the in-
terval of chromosome 2p14 to 2p16-p21 suggested that
this interval is duplicated and inserted into chromosome
3. In the second case, DGAP122, a complex rearrangement
was reported between chromosomes 1, 5, and 9, and the
karyotype was revised to the following: 46,XY,t(1;9;5)(1p-
ter/1q32::9p22-24::5q15/5qter;9pter/9p24::9p22/
9qter;5pter/5q15::1q32/1qter). FISH analysis of this
case revealed even further rearrangements with multiple
possible duplications.
In addition to FISH analyses, selected cases were ana-
lyzed with aCGH (Table 3). Eleven cases were examined
with either Spectral Genomics 2600 BAC arrays or Agilent
Technologies 244K oligonucleotide arrays, and one case
was examined with both. Five cases showed no additional
rearrangements. Six cases showed copy-number losses
ranging in size from 0.5 Mb to ~12 Mb. The 12 Mb loss
seen in DGAP089 was observed cytogenetically, and the
array experiment reﬁned the boundaries of the deletion.
No cases had copy-number gains by array analysis.
After breakpoint regions were narrowed to a minimum
region of ~20 kb with FISH probes, Southern-blot analysis
was performed for 15 breakpoints. These breakpoints were
pursued beyond the limits of FISH analysis because they
harbored the most promising candidate genes in the vicin-
ity of the FISH-mapped breakpoint. Breakpoint localiza-
tion by Southern blotting revealed slight discrepancies be-
tween the localization predicted by FISH mapping and the
Southern-blot analysis in six cases. These six breakpoints
were localized outside the FISH-deﬁned region by an inter-
val ranging from 6 to 32 kb. In one case, DGAP100, the
cloned breakpoint was 8 kb from the terminus within2008
a BAC clone that did not show a split hybridization signal
on metaphase chromosomes. This example demonstrates
the intrinsic difﬁculty in detecting hybridization to both
derivative chromosomes when the breakpoint is located
at the corresponding end of the FISH probe. Unequal distri-
bution of repetitive and single-copy sequences in the BAC
probe could create the same difﬁculty. Use of smaller
probes such as fosmids and PCR products may help tomin-
imize such discrepancies. Our strategy to clone the break-
points incorporates this information by screening for
a breakpoint in the 10 to 30 kb genomic segment ﬂanking
the FISH-deﬁned region.
After breakpoint regions were localized to single restric-
tion fragments, suppression PCR was used to amplify junc-
tion sequences.18 These PCR products were then cloned
and sequenced. With this approach, eighteen breakpoints
have been cloned and sequenced from nine chromosomal
rearrangements (Table 4).
Figure 1. Complexity of DGAP Phenotypes
(A) The multiple systems involved in DGAP cases illustrate the complexity of phenotypes observed.
(B) Most individuals studied have malformations of multiple systems, ranging from one to eight systems.
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Table 1. Phenotype and Karyotype of Selected DGAP Cases
Case No. Phenotype Karyotype Publication
DGAP003 Delayed dentition, gingival hyperplasia, hirsutism, large facial bones
and mandibles, large ears, a markedly enlarged nose with short
columella nasi and saddle deformity, depressed nasal bridge,
hypertelorism with bilateral convergent strabismus, epicanthal folds,
protruding upper lip, hypertrophic papillae on the posterior of the
tongue, bilateral spade-like fingers, skin thickening on the legs,
dysmorphic skeletal features
46,XY,t(3;17)(p14.3;q24.3)dn 21, 33
DGAP006 Mental retardation, developmental delay, absent speech, aggressive
behavior, frontal bossing, epicanthal folds, left eye ptosis, low-set ears,
no binocular fixation searching movements
46,XX,t(1;2)(p32;q11)dn
DGAP009 Mental retardation, eye anomaly, other multiple congenital anomalies 46,XY,t(1;8)(p34;q22)dn
DGAP011 Kallmann syndrome (atrophic testes, azoospermia, cleft lip and palate) 46,XY,t(7;8)(p12.3;p11.2)dn 2
DGAP012 Developmental delay, digitalized thumbs, brachycephaly, microcephaly,
small down-turned mouth, mild midfacial hypoplasia, flat mid-face,
narrow nasal bridge, very small nose, large ears, bilateral epiblepharon
without trichiasis, small hands and feet, absence of emotional
expression, hand flapping, early feeding problems
46,XY,t(11;19)(p11.2;p13.2)dn
DGAP015 Bannayan-Riley-Ruvalcaba syndrome, malignant intracranial hCG-
secreting tumor causing precocious puberty
46,XY,t(10;13)(q23.3;q33)dn
DGAP016 Hypoplastic testes 46,XY,t(8;10)(p11.2;p13)dn
DGAP018 Bilateral osseocutaneous syndactyly of the 3rd, 4th, and 5th fingers;
hypotonia; macrocephaly; forehead and occipital prominence; left inner
thigh hemangioma; developmental delay
46,XX,?dup(2)(p14p?21),ins(2;1)
(?p13;p21p31),ins(3;2)
(q23;p14p?21)dn
DGAP020 Sex reversal, gonadoblastoma, streak gonad, amenorrhea 46,X,t(Y;17)(q11;p13)dn
DGAP025 Developmental delay, scoliosis, syndactyly of toes, learning problems,
masculinized face, hirsutism
46,X,t(X;15)(p22;q26)dn
DGAP032 Kallmann syndrome (hypogonadotropic hypogonadism, and anosmia),
skeletal anomalies, mental retardation
46,XY,t(7;12)(q21.13;q24)dn
DGAP089 Subarachnoid hemorrhage, ventriculomegaly, underdeveloped corpus
callosum, tonic-clonic seizure, severe delays in growth and
development, craniofacial disproportion and dysmorphism, right
cryptorchidism, hypotonia, chronic intestinal obstruction
46,XY,t(1;2)(p31.3;q22.1),
del(2)(q14.3q21)dn
23
DGAP090 Sensorineural hearing loss, Mondini defect, avascular necrosis of the
left femoral head, dermal telangiectasias with ulceration, juvenile
rheumatoid arthritis
46,XY,t(8;9)(q12.1;p21.3),
t(9;11)(q33;q13)mat
34
DGAP095 Seizures, developmental delay, infantile hypotonia, obesity, livedo
reticularis
46,X,t(X;2)(p11.2;q37)dn 32
DGAP097 Developmental delay, infantile spasms, hypotonia, mental retardation,
behavioral problems, facial dysmorphism, myopia, patchy skin
hypopigmentation
46,X,t(X;9)(p22.2;p13)dn
DGAP100 Mental retardation, severe psychomotor delay, mild ventriculomegaly,
failure to thrive, no speech, no ambulation, cleft palate, impaired
hearing, bilateral optic nerve hypoplasia, severe myopia, hypoglycemia,
mild pectus excavatum, gray teeth with caries
46,X,t(X;5)(p11.23;q35)dn
DGAP101 Severe mental retardation, no speech, mild dysmorphism, clinodactyly,
mild hirsutism
46,XY,inv(5)(q13q15)dn
DGAP103 Extreme somatic overgrowth, advanced endochondral bone and dental
ages, a cerebellar tumor, multiple lipomas
46,XY,inv(12)(p11.22q14.3)dn 3
DGAP104 Congenital hydrocephalus, abnormal corpus callosum, periventricular
calcifications, sacral anomaly, hypoplastic kidneys
46,XX,t(1;20)(p31.3;q13.31)dn 23
DGAP105 Aortic coarctation; bicuspid aortic valve; bilateral cryptorchidism and
primary hypospadias; inguinal hernia; widely spaced nipples; short
neck; four hair whorls (three posterior and one anterior); down-slanting
palpebral fissures; bilateral epicanthal folds; broad nose; smooth
philtrum; thin vermilion border; low-set and posteriorly rotated ears
with simplified, thickened helices; mild hypertelorism and strabismus;
developmental delay
46,XY,t(1;5)(p35.3;q31.3)dn
DGAP106 Developmental delay, self-injurious actions and agitation, growth
retardation, strabismus, ptosis, normal MRI
46,XX,t(3;5)(q27;q31.1),
t(11;13)(p15.3;q14.1)dn
DGAP107 Visual defects, limb defects, urinary tract abnormalities, learning
disabilities, genital anomalies, neurological and behavioral defects
46,XY,t(Y;3)(p11.2;p12.3)dn 20
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Table 1. Continued
Case No. Phenotype Karyotype Publication
DGAP112 Microcephaly, advanced bone age and secondary craniosynostosis,
developmental delay, flat nasal bridge, epicanthal folds, strabismus,
short philtrum, thin upper lip, two cafe´-au-lait spots, 2nd toes overlap
3rd toes bilaterally, small labia majora, extra creases on right hand,
wide thumbs and halluces
46,XX,t(3;12)(q13.2;q14),
del(12)(q14q14)dn
DGAP121 Feeding problems at birth, malformed left ear lobe, epicanthal
folds, learning problems, mild hypotonia, mild resolved
scoliosis
46,XX,t(5;13)(q15;q32)dn
DGAP122 Epicanthal folds; hypertelorism; frontal and posterior cowlick;
coarse hair; area of alopecia; history of patchy, intermittent hair
loss; partially attached pinnae; mild micrognathia; mild pectus
excavatum; soft systolic murmur with normal echocardiogram;
developmental delay; renal insufficiency caused by grade II-III
hydronephrosis
46,XY,t(1;9;5)(1pter/1q32::
9p22-24::5q15/5qter;9pter/
9p24::9p22/9qter;5pter/
5q15::1q32/1qter)dn*
DGAP123 Autism 46,XX,ins(16;2)(q22.1;p16.1p16.3)
pat.ish ins(16;2)(wcp2þ;wcp2þ)
36
DGAP127 Failure to thrive; feeding problems; growth retardation; unexplained
weight loss; brachycephaly; flat mid-face; pointed chin; broad,
prominent forehead; deeply set eyes; small mouth; frequent episodes of
abdominal pain; some difficulties with reflux; kidney stones; developing
contractures and spasticity of the ankles, knees, elbows and shoulders;
severe developmental delay; very poor eye contact/interaction; self-
stimulating episodes; episodic discomfort and agitation with no
apparent cause; seizures; muscle biopsy demonstrated partial complex
III deficiency
46,X,t(X;5)(q24;q13)dn
DGAP128 Macrocephaly, significant developmental delay, seizures and cerebral
atrophy
46,XX,t(1;3)(q32.2;q25.2)dn 35
DGAP137 Mild mental retardation, pigment abnormality, VSD, conductive
hearing loss, abnormal thyroid function tests, right eye poor visual
acuity (small pit in right optic nerve), bilateral optic nerve colobomas,
MRI shows 1.5 cm mass behind right globe (no enhancement),
bulbous great toes with convex toenails, ligamentous laxity,
easy bruising
46,XX,der(6)t(6;13)(q23.3;q22)
inv(6)(p21.3q15),der(13)t(6;13)dn
DGAP139 Developmental delay; hypotonia; dolicocephaly; frontal upsweep;
synophrys; long, straight eyelashes; small nares; pronounced philtral
creases; small mouth; flat hemangiomas on back of neck; pectus
excavatum; joint hyperextensibility; feet have increased secondary
creases on both soles; hands have a right Sydney line
46,XY,t(7;13)(p15.3;q14.1)dn
DGAP151 Cleft lip and palate 46,XX,t(2;8)(q33.1;q24.3)dn 19
DGAP157 Global developmental delay, bilateral inguinal hernia, spina bifida
occulta, mild dysmorphic features
46,XY,t(3;10)(p26.3;q26.3)dn
DGAP159 Growth retardation, brachydactyly, bilateral syndactyly of 2nd
and 3rd toes, micrognathia, low-set ears, hypertelorism and single
palmar crease, developmental delay, no oral language, some autistic
and ADD behaviors, abnormal brain CT (5 months of age), moderate
to severe bilateral conductive hearing loss, hypo and hypersensitive
to different tactile stimulation, trouble focusing eyes on close
objects
46,XY,t(8;10)(q13;p13)dn
DGAP166 Seizure disorder, developmental delay, microcephaly, bilateral
epicanthal folds, nose upturned with a thin upper lip and upturned
corners of the mouth, very mild micrognathia
46,XX,inv(2)(p23q31)dn
DGAP167 Mild developmental delay, vertical talus (rocker-bottom foot
deformity), hypotonia
46,XX,inv(18)(q11.2q23)dn
DGAP169 Failure to thrive, feeding problems, growth retardation, bilateral
microtia with profound sensorineural deafness, fused incus and malleus,
incus with absent short process, bilateral Mondini malformation,
abnormal cochlear turn, malformation of the semicircular canals,
micrognathia, anteriorly displaced larynx, small right kidney with renal
cortical thinning, borderline wide interpedicular distance of C-spine (18
mm C7, 15–16 mm C5), developmental delay, abnormal hair distribution
with high forehead, benign precocious thelarche at 9 months that
resolved by 15 months
46,XX,inv(5)(q14q35)dn
(Continued on next page)
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Breakpoint Sequence Analysis
We examined the genomic architecture of the breakpoint
regions. Analysis of the 18 cloned breakpoints revealed
11 microdeletions of 1–16 bp, six insertions of 2–17 bp,
two duplications of 3 and 13 bp, and four rearrangements
without gain or loss of a nucleotide at one or more break-
points. Three of the 18 breakpoints showed multiple types
of sequence changes including deletion and insertion or
duplication (Table 4). In one case (DGAP011), both break-
points were perfectly balanced (i.e., no loss or gain of se-
quence on either derivative chromosome). In eight cases,
breakpoints fell within repetitive sequences including
three LINE, three Alu/SINE, and two LTR elements. Inter-
estingly, both breakpoints in DGAP095 contain AluSx
elements, possibly facilitating formation of this rearrange-
ment via illegitimate recombination.
To explore a possible common mechanism of formation
of the chromosomal rearrangements studied, we searched
for possible common sequence motifs at the breakpoints.
We ﬁrst evaluated 37 motifs listed by Abeysinghe et al.
in their analyses of 235 sequences.24 These motifs either
had previously been noted to be present at rearrangement
breakpoints or are associated with mechanisms (e.g., re-
combination) that might be etiologic in a rearrangement.
Several of the sequence motifs were reported in that study
to be overrepresented at translocation breakpoints. In con-
trast, we found that none of these 37 sequence motifs was
signiﬁcantly overrepresented in our set of breakpoint se-
quences after correcting for multiple-hypothesis testing.
It is possible that the number of breakpoints assessed in
our study was insufﬁcient to replicate the ﬁndings of the
previous study. However, breakpoint sequences analyzed
by Abeysinghe et al. were primarily derived from malig-
nancies, rather than de novo germline rearrangements,
and a different molecular mechanism may reasonably
underlie their origin.24
As a more comprehensive search, we tested partially de-
generate 8-mer motifs by the same method, in which each
motif consisted of six ﬁxed positions and two degenerate
positions (e.g., AGAGNAGN). After testing of the full set
of possibilities for sequence motifs with this structure,
none was found to be overrepresented in the breakpoint
sequences after correcting for multiple-hypothesis testing.
Submission of the breakpoint sequences to the YMF 3.0
motif-ﬁnding tool yielded ATWAGGRA as the top-scoring
motif, with ﬁve occurrences, but the signiﬁcance of this
Table 1. Continued
Case No. Phenotype Karyotype Publication
DGAP173 Mild developmental delay; major depression; generalized anxiety; sleep
apnea; self-injurious behaviors; agitation; tantrums; overgrowth; male-
pattern hirsutism; amenorrhea; impaired glucose tolerance;
hypercholesterolemia and hypertriglyceridemia; elevated testosterone;
deep voice; history of one seizure at 2 yr of age; eczema; acanthosis
nigricans; moles and skin tags; bilateral epicanthal folds; small nose;
complex malocclusion; short, hyperkeratotic palms; 5th finger
brachydactyly and clinodactyly; right elbow extension limitation;
hypoplastic toenails; short feet
46,XX,t(2;11)(q11.2;p13)dn
DGAP174 Overgrowth, right-sided hemihypertrophy, small apical VSD and current
heart murmur, metopic craniosynostosis and hydrocephalus, Arnold
Chiari II malformation, agenesis of the corpus callosum, dysplasia of
the left temporal lobe, scoliosis, developmental delay, attention deficit
hyperactivity disorder, increased red blood cell size, asthma and
seasonal allergies, left inguinal hernia that was surgically repaired,
bilateral epicanthal folds, slight occasional esotropia, high-arched
palate, left-sided head tilt, unsteady gait and uncoordinated
movements with decreased balance
46,XY,t(1;3)(p22;q21),
del(1)(p31.3p32.1)dn
23
DGAP190 Developmental delay, infantile spasms 46,XX,t(X;8)(p22;p21)dn
DGAP200 PDD-NOS, ADHD, conduct disorder with early onset, intermittent
explosive disorder, obesity
46,XY,t(1;2)(q31.3;p16.3)dn 36
*indicates reported karyotype; FISH analyses suggest additional rearrangements that were not characterized further.
Table 2. Deletion Size and Location in DGAP Cases
Case No. Deletion Size Location
DGAP009 1.5 Mb At breakpoint
DGAP020 900 kb At breakpoint
DGAP089 ~12 Mb ~3 Mb from breakpoint
DGAP106 R1.5 Mb At breakpoint
DGAP106 500 - 800 kb At breakpoint
DGAP107 3.4 Mb Different chromosome
DGAP112 750 kb At breakpoint
DGAP137 226 kb - 1.9 Mb At breakpoint
DGAP139 600 kb At breakpoint
DGAP159 3 Mb ~1.75 Mb from breakpoint
DGAP159 6 Mb At breakpoint
DGAP167 8 Mb At breakpoint
DGAP169 500 kb 200 kb from breakpoint
DGAP169 500 kb At breakpoint
DGAP173 2.5 Mb At breakpoint
DGAP174 2.2 Mb ~10 Mb from breakpoint
DGAP190 ~4 Mb At breakpoint
DGAP200 ~500 kb ~2 Mb from breakpoint
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Table 3. Array Comparative Genomic Hybridization Analyses of Selected DGAP Cases
Case No. Imbalance Flanking BACs Region of Imbalance ~Size of Imbalance in Mb Platforma
DGAP089 LOSS RP11-270M20, RP11-472M4 RP11-294I11 to RP11-289K3 12 SG
DGAP107 LOSS ZNF287, DKFZp566O084b LOC201164 to AKAPP10b 3.4 SG,AT
DGAP159 LOSS RP11-659E9, RP11-212P10 RP11-288G19 to RP11-346i3 3.0 SG
DGAP159 LOSS RP11-287021, RP1174N14 RP11-91K20 to RP11-80D10 6.0 SG
DGAP173 LOSS RP11-16H3, RP1-296L11 RP11-79M22 to RP11-79E9 2.5 SG
DGAP174 LOSS RP11-63G10, RP11-5P4 RP11-13N22 to RP4-662P1 2.2 SG
DGAP200 LOSS BC005076, SPTBN1b ACYP2 to SPTBN1b 0.5 AT
DGAP003 NONE — — — AT
DGAP028 NONE — — — AT
DGAP095 NONE — — — SG
DGAP104 NONE — — — SG
DGAP151 NONE — — — SG
a SG ¼ Spectral Genomics 2600 BAC array, AT ¼ Agilent Technologies 244K (G4411B).
b 60-mer oligonucleotides based on sequence from the genes listed.motif is uncertain because it is unclear how many hypoth-
eses are tested by this algorithm. Further testing of this mo-
tif as a speciﬁc hypothesis can be performed as additional
examples of breakpoint sequences are determined.
Forty-seven breakpoints from 27 cases were positioned
and examined for candidate genes. Genes were directly dis-
rupted by 34 breakpoints (Table 4): 22 within introns
(ranging in size from 2.9 to 379 kb with an average size of
63 kb), one in a 30 UTR, and 11 not yet precisely localized.
Only 13 breakpoints fell in nongenic regions. These data
support the hypothesis that the chromosomal rearrange-
ments in these phenotypically abnormal patients fre-
quently disrupt or dysregulate a gene (or genes). Three
cases revealed gene fusions that produce fusion transcripts
identiﬁed by RT-PCR (DGAP011, 012, and 107). Although
fusion transcripts frequently result from translocations in
neoplasms, they have rarely been described in constitu-
tional rearrangements.5 The clinical signiﬁcance of the
fusion transcripts produced in DGAP011 and DGAP012
remain to be determined. The DGAP107 fusion transcript
results in a dominant-negative ROBO2 protein that abro-
gates downstream signaling.20
Discussion
In this study, we describe the most detailed analysis to date
of apparently balanced chromosomal rearrangements in
individuals with an abnormal phenotype. We have lever-
aged recent advances in the Human Genome Project and
subsequent resources that have become available to lo-
calize functionally important genes on human chromo-
somes. In the process of uncovering these genes, we have
analyzed 77 breakpoints from 40 chromosomal rearrange-
ments, including sequence analysis of 18 of these break-
points.
Recent reports have suggested that apparently balanced
constitutional translocations in patients presentingwith ab-
normal phenotypes may be more complex when analyzed
at a higher level of resolution.16,17 Our analyses revealed
cryptic rearrangements in 15 of 40 (~37%) cases. Themajor-The Aity of deletions occurred at breakpoints; however, in ﬁve
cases, additional rearrangements were identiﬁed at a dis-
tance (0.2 Mb to 10 Mb) from the respective breakpoints.
In DGAP107, the additional deletion was on a chromosome
not involved in the reported translocation. It is reasonable
to hypothesize that deletions at breakpoints may have oc-
curred in the course of the formation of the chromosomal
rearrangements. Deletions at a distance from breakpoints
may be unrelated to the rearrangement, or may reﬂect
a more complex mechanism that promotes both interchro-
mosomal exchange and intrachromosomal deletion.
Gribble et al. reported detecting rearrangements of previ-
ously unsuspected complexity in six out of ten patients
after detailed analysis of apparently balanced transloca-
tions.17 We observed approximately two-thirds the rate
of additional complexity as compared to this study, poten-
tially reﬂecting the different patient populations analyzed.
The abnormal phenotypes for the patients analyzed by
Gribble et al. were largely described as learning disabilities
and developmental delay.17 Although we analyzed pa-
tients with these abnormalities as part of a more complex
phenotype, we also analyzed patients with a greater variety
of phenotypes (Figure 1 and Table 1). It also should be
noted that Gribble et al. used aCGH at ~1 Mb resolution
and array painting to characterize the rearrangements
in their study.17 Although we did analyze a subset of our
rearrangements (11 cases) with aCGH, not all cases were
subjected to a genome-wide assessment. However, our
analyses allowed us to detect complexities at or near the
breakpoints and would only have failed to uncover a rear-
rangement at a great distance from or in a region unrelated
to the reported rearrangements. aCGH is clearly a valuable
technology to complement FISH characterization of appar-
ently balanced chromosomal rearrangements.
The mechanism of formation of these nonrecurrent
chromosomal rearrangements is still unknown. Recip-
rocal translocations may be the result of two random
double-strand breaks followed by ligation repair of these
breaks by homologous recombination or nonhomologous
end joining (NHEJ). For those rearrangements withoutmerican Journal of Human Genetics 82, 712–722, March 2008 719
Table 4. Breakpoint Localization and Sequence Analysis
Case No. Rearrangement t(a;b) or inv(ab) Site on der(a) Site on der(b) Sequence Changes
DGAP003 t(3;17)(p14.3;q24.3) Intron 25 of CACNA2D3 NGR Chr 3: 11 bp deletion
Chr 17: 1 bp deletion
DGAP006 t(1;2)(p32;q11) Intron 4 of SSBP3 Intron 6 of TMEM87B
DGAP011 t(7;8)(p12.3;p11.2) Intron 15 of TNS3 Intron 2 of FGFR1 balanced
DGAP012 t(11;19)(p11.2;p13.3) Intron 16 of PHF21A Intron 5 of ELAV Chr 11: 5 bp deletion
Chr 19: 5 bp deletion
DGAP015 t(10;13)(q23.3;q33) PTEN
DGAP016 t(8;10)(p11.2;p13) NGR NMT2
DGAP025 t(X;15)(p22;q26) NGR Intron 18 of CHD2
DGAP032 t(7;12)(q21.13;q24) NGR Intron 2 of RMST Chr 7: 3 bp deletion
Chr 12: 17 bp insertion
DGAP089 t(1;2)(p31.3;q22.1),
del(2)(q14.3q21)
Intron 7 of NFIA NGR
DGAP090 t(8;9)(q12.1;p21.3),
t(9;11)(q33;q13)mat
NGR Intron 5 of MTAP Chr 8: 3 bp duplication
Chr 9: 7 bp deletion, 12 bp
insertion, 13 bp duplication
DGAP095 t(X;2)(p11.2;q37) NGR Intron 1 of DGKD
DGAP097 t(X;9)(p22.2;p13) Intron 5 of CXORF15 NGR Chr X: 2 bp insertion
Chr 9: 7 bp deletion,
2 bp insertion
DGAP100 t(X;5)(p11.3;q35) Intron 2 of UTX
DGAP101 inv(5)(q13q15) Intron 2 of C5ORF36
DGAP103 inv(12)(p11.22q14.3) NGR Intron 3 of HMGA2
DGAP104 t(1;20)(p31.3;q13.31) Intron 2 of NFIA Intron 2 of C20ORF32
DGAP105 t(1;5)(p35.3;q31.3) Intron 1 of AHDC1 30UTR of MATR3 Chr 1: 16 bp deletion
Chr 5: 7 bp insertion
DGAP107 t(Y;3)(p11.2;p12.3) Intron 1 of PCDH11Y Intron 2 of ROBO2 Chr Y: no change
Chr 3: 1 bp deletion,
2 bp insertion
DGAP112 t(3;12)(q13.2;q14)
del(12)(q14q14)
SLC16A7
DGAP121 t(5;13)(q15;q32) NGR DOCK9
DGAP123 ins(16;2)(q22.1;p16.1p16.3) Intron 5 of NRXN1 NGR
DGAP127 t(X;5)(q24;q13) MBNL3 GPR98
DGAP128 t(1;3)(q32.2;q25.2) Intron 3 of SYT14 NGR
DGAP151 t(2;8)(q33.1;q24.3) Intron 2 of SUMO1 NGR Chr 2: 9 bp deletion,
29 bp insertion
Chr 8: no change
DGAP157 t(3;10)(p26.3;q26.3) ANK3
DGAP166 inv(2)(p23q31) SCN1A
DGAP174 t(1;3)(p22;q21,del(1)
(p31.3p32.1)
NEGR1
NGR denotes nongenic region.sequence similarity at the breakpoints, NHEJ may be in-
volved in translocation formation because additional geno-
mic alterations such as small deletions, insertions, or dupli-
cations at the breakpoint junctionshave beendetected.25–27
Few constitutional rearrangements have been examined
at the sequence level to elucidate possible mechanisms of
formation.24,28 Examination of 18 breakpoints sequenced
in this study revealed one case with no loss or gain of ma-
terial at the breakpoint junction and the majority with
small duplications, insertions, and deletions. These data
would suggest a mechanism of NHEJ in the formation of
these rearrangements. Only one case, DGAP095, exhibited
at both breakpoints a degree of sequence similarity (AluSx
sequence) that may have mediated formation of the trans-
location. Although analyses of the breakpoints did not un-
cover a speciﬁc sequence or motif that would support a hy-720 The American Journal of Human Genetics 82, 712–722, Marchpothesis for a mechanism of formation, these data may be
a valuable ﬁrst step to future studies to elucidate a mecha-
nism (or mechanisms) of chromosomal rearrangement.
Cases that revealed greater karyotypic complexity (Table
2) may be the result of a different mechanistic origin. The
large deletions found at and away from the breakpoints
could result from chromosomal pulverization at the site
of rearrangement rather than the more precise double-
strand breaks described above. Repair of these fragmented
chromosomes could result in the large deletions observed.
Recent analyses of cancer cell lines and a bone-marrow
specimen from a patient with myeloproliferative disorder
demonstrate deletions both at the breakpoints and at
a site distant from the breakpoints.29–31
DGAP affords a unique opportunity to discover genes in-
volved in developmental processes that otherwise could be2008
difﬁcult or essentially impossible to identify;2,19,20,32–35
mutations in some of these genes may not be found segre-
gating as Mendelian traits in human families because
affected individuals may have a genetic ﬁtness of zero. In
keeping with the overarching goal of gene discovery in
the DGAP study, genes were found to be disrupted at 34
breakpoints. Seven candidate genes have functions that
remain to be investigated.
In addition to identifying new genes, this gene-discov-
ery approach may uncover known genes with previously
unappreciated roles in developmental pathways. Examples
include SUMO1 (MIM 601912) in palatal development,19
ROBO2 (MIM 602431) in urinary tract development,20
and NFIA (MIM 600727) in urinary tract and central ner-
vous system development.23 Thus far, we have shown dis-
rupted genes to be contributory to the patient’s phenotype
in 12 cases (Table 1).
Our data support the hypothesis that apparently bal-
anced chromosomal rearrangements are valuable biologi-
cal landmarks for genes important in human develop-
ment. Although cryptic genomic disturbances may also be
observed in individuals with congenital anomalies and ap-
parently balanced rearrangements by conventional cy-
togenetics, their presence does not necessarily diminish
the value of a particular case in contributing to the un-
derstanding of the genetic basis of a developmental
disorder.20,23 In sum, naturally occurring chromosomal
rearrangements continue to be a rich resource for gene
discovery and annotation.
Supplemental Data
The sequence of DGAP cases analyzed for motifs can be found
with this article online at http://www.ajhg.org/.
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